Guidance

Standards for sickle cell and thalassaemia screening

This document sets out the quality standards for the sickle cell and thalassaemia (SCT) antenatal and newborn screening programme

• From: Public Health England
• Published: 1 November 2011
• Last updated: 8 February 2018 — See all updates

This publication was withdrawn on 4 March 2019

This page has been replaced by a newer version. Go to: Sickle cell and thalassaemia screening programme: standards.

Documents

[Withdrawn] Sickle cell and thalassaemia screening: programme standards

Ref: PHE publications gateway number 2016644

PDF, 920 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This publication explains the programme standards for monitoring the SCT antenatal and newborn screening programme.

The generic newborn blood spot screening standards also apply.

Published 1 November 2011

Last updated 8 February 2018 + show all updates

1. 8 February 2018

   Addition of links to inheritance risk table from Standard 5 definitions

2. 1 March 2017

   Publication of revised programme standards that will apply from 1 April 2017 and archiving of previous version.

3. 1 November 2011

   First published.